课题基金 / 基金详情

The Development of Bone Substitute Added with Bone Morphogenetic Protein and Clinical Application

The Development of Bone Substitute Added with Bone Morphogenetic Protein and Clinical Application
添加骨形态发生蛋白的骨替代品的研制及临床应用
批准号:
01870086
负责人:
YAMAZAKI Yasuharu
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B).
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

YAMAZAKI Yasuharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
[Bone Morphogenetic Protein (BMP)]Amino acid sequences of six bone morphogenetic proteins (BMPs) were reported by Wozney, j. et al. The amino acid sequences for our final highly purified protein from bovine bone show considerable homology to BMP-3.[Bone substitute added with BMP]In TCP (Tricalcium phosphate) or HA (Hydroxyapatite) mixed with BMP implanted into the mouse femoral muscle, it was confirmed that BMP induced bone formation around and on the surface of those particles. There were no difference between the yield of new bone of BMP/HA (Hydroxyapatite) or BMP/TCP (Tricalcium phosphate) composite. However, We found the yield of new bone of it was less than that of BMP alone. This would appeared to indicate that BMP was spread within a short period in vivo, and tissue differentiation was disturbed by HA or TCP. Therefore, an effective BMP delivery system from synthetic vehicle for concentrating BMP was required. Then we investigated the morphologic sequence of a response to a BMP/ … More PLP (Plaster of Paris) composite implanted into the mouse femoral muscle. Minimum crude BMP alone dose for bone induction was needed 3mg, on the other hand, in BMP/PLP (1 : 5) composite, that was reduced up to one mg. In more purified BMP (the activity was four times greater than that of crude-BMP), BMP dose was, furthermore, decreased up to 0.25mg in BMP/PLP (1 : 10) composite. Also the BMP/PLP composite implanted into the bone area of rat and monkey induced active bone formation. These results suggest that PLP composite system is one of the suitable BMP delivery systems currently available.[Clinical application]For the observation of clinical usefulness of BMP, autodecalcified dentin, it was already reported that BMP was included in the dentin, was prepared. That powder was implanted into bone defects after resection of oral and maxillofacial diseases. In results, autodecalcified dentin did not cause a foreign body reaction and inflammation, but we did not, contrary to expectation, confirmed bone formation induced by that dentin in roentgenograms. The some cause of it is to be sought that in partly clinical detection methods of induced bone by BMP, almost the deficiency of BMP in autodecalcified dentin and target cell in host tissue. These important problems must be solved in future. Less
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Yamazaki,Y.: "Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris" Clinical Orthopaedics and Related Research. 234. 240-249 (1988)
Yamazaki,Y.:“小鼠股骨肌肉对骨形态发生蛋白和熟石膏复合物植入物的反应”临床骨科及相关研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oida,S.: "Bone morphogenetic protein (BMP) and transforming growth factorーβ(TGFーβ)in human bone matrix." Clinical Orthopaedics and Related Research.
Oida, S.:“人体骨基质中的骨形态发生蛋白 (BMP) 和转化生长因子-β (TGF-β)。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasuharu Yamazaki: "Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymer capsule." Society for Biomaterials. (1991)
Yasuharu Yamazaki:“使用可生物降解的聚合物胶囊通过牛骨形态发生蛋白异位诱导软骨和骨。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Possibility of bone substitute by using tissue engineering, concerning the bone grafting operation to the alveolar cleft of CL/CP.
    • 批准号:
      23592942
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      YAMAZAKI Yasuharu
    • 依托单位:
    The cryopreservation of umbilical cord blood derived mesenchymal stem cells and the possibility of clinical application of those cells to cleft lip and palate patient.
    • 批准号:
      20592345
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      YAMAZAKI Yasuharu
    • 依托单位:
    Quality and safety of cryopreserved human mesenchymal stem cell(MSC) during serial subculture
    • 批准号:
      18592198
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      YAMAZAKI Yasuharu
    • 依托单位:
    Development of a hybrid bone substitute with cryopreserved auto stem cell (human bone marrow derived mesenchymal stem cell)
    • 批准号:
      16592018
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2004
    • 负责人:
      YAMAZAKI Yasuharu
    • 依托单位:
    海外基金